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Abstract
Background: Neurologists play an essential role in facilitating the patient’s process of living with Parkinson’s
disease (PD). The Living with Chronic Illness Scale-PD (LW-CI-PD) is a unique available clinical tool that evaluates
how the patient is living with PD. The objective of the study was to analyse the LW-CI-PD properties according to
the Rasch model.
Methods: An open, international, cross-sectional study was carried out in 324 patients with Parkinson’s disease
from four Latin American countries and Spain. Psychometric properties of the LW-CI-PD were tested using Rasch
analysis: fit to the Rasch model, item local independency, unidimensionality, reliability, and differential item
functioning by age and gender.
Results: Original LW-CI-PD do not fit Rasch model. Modifications emerged included simplifying the response scale
and deleting misfit items, the dimensions Acceptance, Coping and Integration showed a satisfactory fit to the
Rasch model, with reliability indices greater than 0.70. The dimensions Self-management and Adjustment to the
disease did not reach fit to the Rasch model.
Conclusion: Suggestions for improving the LW-CI-PD include a multidimensional and shorter scale with 12 items
grouped in three subscales with a simpler response scheme. The final LW-CI-PD Scale version is a reliable scale,
with good internal construct validity, that provides Rasch transformed results on linear metric scale.
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Background
Parkinson’s disease (PD) is the second most common
neurodegenerative chronic condition with a prevalence
of 1% in people over the age of 60 affecting 10 million
people worldwide [1]. It is a complex and disabling dis-
order manifested through a combination of motor and
non-motor symptoms that generate an important impact
on the daily living [2]. Throughout the PD course, pa-
tients do not only experience a progressive intensifica-
tion of symptoms, but also have to deal and cope with
an increasing limitation in all areas of their day to day,
as a consequence of the disease [3, 4]. Several studies
show that living with PD affects the patients’ physical
state together with other essential aspects in their lives,
such as the psychological, social and spiritual ones [5, 6].
Consequently, evaluating how patients live with PD
using clinical measures becomes fundamental for the
healthcare system [7].
The Living with Chronic Illness Scale-Parkinson’s dis-
ease (LW-CI-PD) scale is the only available instrument
in clinical practice and research to evaluate the degree of
living with a neurodegenerative condition as PD from
the patient perspective [8]. The LW-CI-PD is composed
by the following five sections: domain 1. Acceptance re-
fers to recognize and assume the disease (4 items); do-
main 2. Coping alludes to face with PD (7 items);
domain 3. Self-management refers to know what to do
and how to control the disease (4 items); domain 4.
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Integration means making the disease part of the day-to-
day of the person (5 items); and domain 5. Adjustment
refers to the transformation that the person living with
PD suffers not only in the daily living but also in his/her
self-identity (6 items). The LW-CI-PD is a new self-
reported measuring scale that has been recently vali-
dated in PD and other prototypical chronic conditions
showing satisfactory psychometric properties [8, 9]. All
studies have been carried out by using a classic test the-
ory approach to evaluate reliability, validity and sensitiv-
ity to change along with acceptability and other
parameters, mostly based on correlations and mean-
difference analyses. The application of the Rasch meas-
urement analysis [10] combined with the classic test the-
ory approach is recommended for evaluating patient
outcome report measures [11].
The Rasch model [10] is one of the most used applica-
tions of item response theory, completing the informa-
tion provided by the classic test theory because it
provides additional and relevant information about the
measurement properties of a scale, like for example the
LW-CI-PD. The Rasch model assess the internal con-
struct validity, the optimal scoring scheme, unidimen-
sionality, item fit, item local independency, and item bias
by subgroups of respondents. Scales that fit the Rasch
model provide interval linear measure that establishes
equal intervals between the values and could be used in
parametric analysis.
The objective of the present study was to analyze the
LW-CI-PD properties according to the Rasch model.
Suggestions for modification of the LW-CI-PD are pre-
sented accordingly.
Methods
Design
International and cross-sectional study of a sample of
consecutive patients living with PD. This study is part of
a bigger research project with the general aim to achieve
a unique and international self-reported scale to evaluate
the process of Living with PD as other long-term condi-
tions all over the word (Spain, South America, UK).
Participants
A consecutive cases sampling was applied to participant
identification. The sample was formed by 324 patients
with PD attended in specialized units of movement dis-
orders of seven public and private centres from Cuba
(n = 50), Argentina (n = 60), Ecuador (n = 60), Mexico
(n = 53) and Spain (n = 101). Inclusion criteria were: 1)
patients with a PD diagnosis by a neurologist according
to international criteria [12]; 2) native Spanish-speaking
patients; 3) able to read and understand properly ques-
tionnaires; and 4) able to provide informed consent. Ex-
clusion criteria were: 1) patients with other
neurodegenerative disorders related to PD; 2) cognitive
deterioration previously and formally diagnosed by the
neurologist; 3) acute disorder or other pharmacological
effects that negatively influenced in the assessment; and
4) refusal to participate in the study.
Assessments
Sociodemographic data such as age, gender, marital sta-
tus, employment situation and educational level were
collected. Also, PD historic data were collected, such as
age at PD onset, PD duration and PD treatment dur-
ation. All scales were used in the respective Spanish ver-
sions. In addition to sociodemographic and PD historic
data, the following measures were used by the
neurologist:
Hoehn and Yahr (HY) stage [13] is a worldwide used
tool to measure the overall severity of PD, which
comprises five stages.
Scales for Outcomes in Parkinson’s Disease-Motor
(SCOPA-M) [14] is a specific PD measure to evaluate
motor symptoms. Its 21 items are grouped into the fol-
lowing three sections: 1) examination, 2) daily living ac-
tivities and, 3) motor complications. The score for each
item ranges between 0 (normal, no affectation) and 3
(severe affectation) and the total scale score is 0–75.
Clinical Impression of Severity Index-PD (CISI-PD)
[15] it is a scale to evaluate the global impression of PD
severity of the patient according to the following four
areas: 1) motor signs, 2) disability, 3) motor complica-
tions, and 4) cognitive status. The total score ranges
from 0 to 24.
LW-CI-PD was also used [8]. It is a 26-item self-
reported scale that measures the degree of living with
PD in terms of acceptance (4 items), coping (7 items),
self-management (4 items), integration (5 items) and
adjustment (6 items) [8]. It is scored on a 5-point
Likert-type scale ranging from 0 (never/nothing) to 4
(always/a lot). LW-CI-PD total score ranges from 0
(negative living with PD) to 104 (positive living with
PD).
Data collection
Participant recruitment process was carried out between
May 2018 and June 2019. The participant of this study
that was people living with PD filled in the scales during
the consult with their neurologist. In order to ensure
homogeneity and reproducibility of the procedure of
data collection a standardized protocol was established
with clear steps as explaining the research study slowly;
asking about doubts; reading out load instructions of the
scales and its answer options; writing a check mark in
the answer chosen by the patient and giving participants
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time to complete it. The median time to complete all
the measures was approximately 30–40 min.
Ethical aspects
The study was approved by the Ethics Committee of the
University of Navarre (reference number 071/2014) and
all included centres. Patients signed the written consent
to participate voluntarily without any compensation for
this, after receiving the appropriate information. All
data, and information about the participants’ identity,
were handled in full confidentiality throughout the re-
search process.
Data analysis
The Rasch model purports that an answer to an item is
a function of the item’s difficulty (or level of measured
construct) and the person’s ability (or experienced level
by the person), expressed in logits. There are several ex-
cellent tutorials that explain in detail Rasch analysis for
health sciences [16, 17], so here only the main aspects
are summarized. The following measurement properties
were assessed: fit to the Rasch model, unidimensionality
[18], appropriateness of the response scale, item local in-
dependency, reliability (Personal Separation Index, PSI),
and item-person distribution. Differential item function-
ing (DIF) was tested by age (split by the median: up to
68 years, 68 years and more) gender, country, PD dur-
ation (split by the median: up to 10 years, 10 years and
more) and HY stage [19]. We used the top-down purifi-
cation approach to see if DIF cancelled out [20]. Rasch
analyses were performed iteratively, with small modifica-
tions of the scale until model fit was achieved. The par-
tial credit model for polytomous items was used as
indicated by the likelihood ratio test (p < 0.001) [21]. We
used the statistical software RUMM2030 to perform the
Rasch analyses [22].
Results
Three hundred tw enty four patients with PD, 52.78%
men, mean age (standard deviation, SD) of 66.67 (SD:
10.68; range: 36–94) years were included. Two thirds
(66.36%) were married, 42.90% were retired, and 31.79%
had primary or secondary education levels. The distribu-
tion according the HY stages was: 8.64% in stage 1;
55.25%, stage 2; 30.56%, stage 3; 4.01, stage 4; and 1.54%
in stage 5. The SCOPA-M score for the total sample was
22.34 (SD: 11.26), and for the CISI-PD 7.61 (SD: 4.00).
Analyses were performed separately for each one of
the dimensions. Initially, all dimensions showed a misfit
to the Rasch model, and thus modifications were per-
formed iteratively until a model fit was achieved. Never-
theless, dimensions Self-management and Adjustment to
the disease did not reach model fit. Table 1 shows the fit
indices of the Acceptance, Coping and Integration di-
mensions, after model modifications, to the Rasch
model. Item estimates are presented in Table 2.
The following modifications were performed to the di-
mension Acceptance: rescore item 1 (I get upset every
time I think I have PD) by collapsing the second and
third response categories, and deletion of item 2 (I am
ashamed of PD and I hide it to others) due to a high fit
residual (2.519). The resulting 3-item scale showed a
good fit to the Rasch model, χ2(12) = 17.296, p = 0.138,
PSI of 0.795, item local independency, unidimensionality,
and absence of DIF by age, gender, PD duration and HY
stage. However, DIF by country was found in all items,
with an inconsistent pattern across items. The item dis-
tribution presented mean (M) = 0.175 logits, SD = 1.011,
and a no floor effect (13.3%). Fig. 1 shows the person
item-distribution.
Several item of the Coping dimension showed disor-
dered thresholds, which were corrected by collapsing
categories 2 and 3. In addition, items 8 (I try to lean on
Table 1 Fit of the LW-CI-PD dimensions to the Rasch model (results for Acceptance, Coping and Integration dimensions are
shown.after model modifications)
Ideal values Acceptance Coping Self-management Integration Adjustment to
the disease
Number of items 3 6a 4 4 6
Item residual Mean 0 0.175 0.366 0.283 0.238 0.795
SD 1 1.011 1.248 1.358 1.203 1.149
Person residual Mean 0 −0.209 −0.565 0.972 0.748 0.249
SD 1 2.167 1.577 1.688 1.562 1.141
Chi-square Value 17.296 33.471 29.21 28.232 43.206
Prob. > 0.05/number of items 0.134 0.015 0.0006 0.0297 0.000146
PSI > 0.70 0.798 0.765 0.67 0.728 0.663
Unidimensional test
CI test Binomial
(LCI < 0.05) 0.0401
(0.016, 0.064)
0.0216
(−0.002, 0.045)
0.0185
(−0.005, 0.042)
0.0401 (0.016–0.64) 0.0154
(− 0.008, 0.039)
SD Standard deviation, PSI Person separation index, Prob. probability, CI Confidence interval, LCI Lower confidence interval
a Included two items 9, for younger and older adults Unidimensionality results before splitting item 9
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things that are important in my life), and 11 (I express my
feelings so other people know how I feel and could help me)
were deleted due to misfit (− 2.950 and 8.505, respectively).
Item 9 (I hope the situation with PD improves) presented to
DIF by PD duration and age, indicating that younger patients
report higher coping scores than the older ones, for the same
coping level. After splitting item 9 due to DIF by age, a good
model fit was obtained, with χ2(18) = 33.471, p= 0.015, PSI =
0.765, unidimensionality, item local independency, item dis-
tribution M=0.366, SD= 1.248, no DIF for the rest of the
items, and a small ceiling effect (12.963%). Also, DIF by
country in items 7 and 9 was cancelled with the top-down
purification procedure (p-value = 0.160). The person-item
distribution is shown in Fig. 1.
In the Integration dimension, item 18 (I have PD in
mind when doing activities, tasks and/or plans) showed
misfit (3.118) and therefore was removed, and the re-
sponse scales of all items but one (item 20; Although I
have PD I feel satisfied with my life) were recoded by col-
lapsing the second and third response categories. The final
model presented an adequate fit, χ2(16) = 28.23, p = 0.029,
PSI = 0.728, unidimensionality, item local independency,
no DIF by age, gender and HY stage. Item 17 presented
DIF by PD duration; and items 18, 20 and 21 DIF by
country, with an inconsistent pattern across items. The
item distribution M = 0.238, SD = 1.203, and a small ceil-
ing effect (9.878%; Fig. 1).
Discussion
The LW-CI has been successfully used in PD studies in
a wide range of countries [8] as well as in other chronic
conditions [9]. However, this study makes an important
contribution to understanding the measurement proper-
ties associated with the use of LW-CI in PD according
to Rasch model, a powerful item response theory tool.
This is the first study to analyze the psychometric prop-
erties of the LW-CI-PD using Rasch analysis.
The results emerged on this study indicate that the
original LW-CI, when applied to PD patients, fits the
Rasch model after performing some changes. The ori-
ginal scale included response categories that respondents
are not totally able to differentiate, two subscales did not
fit the model, three items that measured constructs
other than living with PD, one redundant item was
found, and the confirmation of multidimensionality was
confirmed.
According to Rasch model, the LW-CI-PD is multidi-
mensional, which supports the use of subscores instead
of a single total score. This means that the LW-CI-PD
measures different constructs (the subscales) and thus
dimension scores should be used. This result completely
fits with the theoretical framework carried out about liv-
ing with a chronic illness as PD where it is defined as a
multidimensional process with dynamical and cyclical
characteristics [23]. According to theoretical bases and
Table 2 Individual item fit residual for final Rasch analysis of the Acceptance, Coping and Integration dimensions
Item (response categories) Location Standard Error Fit Residual Chi-Square (df = 4) Probability
Acceptance
1. I get upset every time I think I have PD (0–3) − 0.459 0.104 0.972 6.775 0.148
3. I get angry when having PD symptoms (0–4) 0.238 0.081 −0.962 7.341 0.119
4. It bothers me to change the way I live and sacrifice
important things in my life because of PD (0–4)
0.221 0.081 0.515 3.181 0.528
Coping
5. I try to cope and fight the diesase −0.220 0.081 0.289 3.274 0.35127
6. I am interested in looking for things that motivate
me not to focus only in PD (0–3)
0.204 0.082 0.516 4.614 0.20237
7. I try to see the positive side of PD (0–3) 0.123 0.079 2.01 10.159 0.01726
9. (younger age). I hope the situation with PD improves (0–3) −0.329 0.098 −0.524 8.202 0.04202
9. (older age). I hope the situation with PD improves (0–3) 0.124 0.087 −1.448 5.796 0.12197
10. I have someone who listens to me and understands
what I am living with PD (0–3)
0.099 0.080 1.352 1.427 0.69931
Integration
16. I have integrated PD in my daily living and all things
related to it (0–3)
−0.148 0.084 1.786 5.225 0.265
17. Despite PD, I lead a life as normal as possible (0–3) −0.240 0.085 −1.035 15.345 0.004
19. I am as interested and I have the same illusion in leisure
activities as before having PD (0–3)
0.414 0.085 0.483 5.393 0.249
20. Although I have PD I feel satisfied with my life (0–4) −0.026 0.073 −0.281 2.269 0.686
PD Parkinson’s disease, Df degrees of freedom
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the results emerged in this study, the LW-CI-PD is a rat-
ing scale that will facilitate clinical specialists to identify
the dimension(s) which is making a patient with PD de-
velop negative and/or positive outcomes in the process
of daily living with the disease. In this way, person-
centred interventions could be developed accordingly,
and consequently improving the patient’s quality of life
and wellbeing.
Two subscales (Self-management and Adjustment)
did not fit the Rasch model. This modification,
pending of confirmation in further studies, might
facilitate the usefulness of the LW-CI-PD in daily
clinical practice since it provides a shorter and eas-
ier tool with direct applicability in patients with
PD. More research is needed to confirm these
results.
Fig. 1 Person-item distribution for dimensions Acceptance (top), Coping (middle) and Integration (bottom) dimensions, after model modifications
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In the same way, four items were removed, one be-
cause of redundancy and two others because they mea-
sured constructs different from their respective
dimensions. Item 8 (I try to lean on things that are im-
portant in my life) was removed because of redundancy.
When applied to PD patients, trying to lean on things
that are important in the patient life is probably more
related to PD integration in daily living rather than to
coping [24]. Items 2, 11 (I express my feelings so other
people know how I feel and could help me) and 18 (I
have PD in mind when doing activities, tasks and/or
plans) were removed. Item 2 (I am ashamed of PD and I
hide it to others) focuses on shame in PD, which might
be personality-related and separate from acceptance [25,
26]. PD-related shame emerged from motor and non-
motor symptoms, from loss of autonomy and need for
help, and from perceived deterioration of body image
[25], which is more associated with PD adaptation rather
than acceptance. Item 11 (I express my feelings so other
people know how I feel and could help me) was also re-
moved confirming previous classic test analysis carried
out in PD [8] showing inappropriate location according
to the multitrait-scaling analysis and low inter-item cor-
relation values. The content of item 18 (I have PD in
mind when doing activities, tasks and/or plans) does not
seem related to PD integration because having in mind
PD is more connected to be aware of the disease and its
symptoms, and in particular with non-motor symptoms
[27, 28] rather than on integration. Besides, previous
multitrait-item validity analysis carried out in PD [8] also
corroborates the inappropriate location of item 18 in its
domain (integration) and consequently, the suitability to
remove it.
A unique contribution of Rasch analysis is the possibil-
ity of checking empirically how well the response cat-
egories are working. Several items showed disordered
thresholds, which indicates that patients were not able
to differentiate between the second and third response
categories (rarely/almost nothing and sometimes/some-
thing). Indeed, the response categories “almost nothing”
and “something” seem quite close. The score structure
initially proposed for the LW-CI-PD [8] was done based
on frequency distribution of raw scores. This study,
pending confirmation by subsequent Rasch analyses,
proposes the same response scale, but it requires differ-
ent codification for the times. Instead of using a coding
scheme from 0 to 4, items should be coded from 0 to 3
by giving the score 1 to the second and third response
category.
All items were free from DIF by gender, age and dis-
ease severity, except one (item 9, I hope the situation
with PD improves), which showed DIF by age. This indi-
cates that older PD patients are more hopeless than
younger PD patients. Younger patients overestimate
scores, whereas older patients underestimate for the
same coping level. PD population studies [29] did not
find statistically significant results that could confirm
this finding. However, in a general population, an associ-
ation between older age and hopelessness was found
[30]. To avoid the potential impact of this bias on the
scale results, the item 9 was splitted with a good model
fit. In addition, one Integration item showed bias by dis-
ease duration, and three Integration items and all Ac-
ceptance items displayed DIF by country. Caution
should be taken when comparing results cross-
nationally. However, further studies are needed to con-
firm these DIF results with larger samples and other
settings.
According to the Rasch analysis, it is proposed a
shorter modified version of the LW-CI-PD with 12 items
grouped in three subscales and a simpler scoring
scheme. However, further research is needed to replicate
the results obtained in this study. Once replication of a
stable model is achieved across different chronic diseases
and countries, a conversion table can be used to trans-
form raw scores to linear measures, without requiring a
Rasch analysis for each data set.
This study presents some limitations relating the sam-
ple. The first concern is that only 1.54% of the sample
presented advanced PD according to the H&Y staging
(stage 5). This is common to many studies with PD pa-
tients and indicates the need to design studies targeted
to advanced PD. It would be very interesting to perform
Rasch analysis on a sample with advanced PD patients
to examine how this would affect LW-CI-PD targeting.
Another limitation of this study is that patients were re-
cruited from different settings, forming a heterogeneous
sample. However, this feature increases external validity.
Conclusion
Through this Rasch analysis, unique information about
the measurement properties of the LW-CI-PD has been
provided. A shorter version, with fewer items and a sim-
pler response scheme, is thus proposed. The resulting
LW-CI-PD is a reliable, with good internal construct
validity.
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